Table of Contents Table of Contents
Previous Page  27 / 78 Next Page
Information
Show Menu
Previous Page 27 / 78 Next Page
Page Background

DCMS online

. org

Northeast Florida Medicine

Vol. 66, No. 4 2015

27

Inflammatory Bowel Disease

32. Stienecker K, Gleichmann D, Neumayer U, et al.

Long-term results of endoscopic balloon dilatation of

lower gastrointestinal tract strictures in Crohn’s disease:

a prospective study.

World J Gastroenterol.

2009 Jun

7;15(21):2623–7.

33. Foster EN, Quiros JA, Prindiville TP. Long-term

follow-up of the endoscopic treatment of strictures in

pediatric and adult patients with inflammatory bowel

disease.

J Clin Gastroenterol.

2008 Sep;42(8):880–5.

34. Thomas-Gibson S, Brooker JC, Hayward CM, et al.

Colonoscopic balloon dilation of Crohn’s strictures: a

review of long-term outcomes.

Eur J Gastroenterol Hepa-

tol.

2003 May;15(5):485–8.

35. Wibmer AG, Kroesen AJ, Grone J, et al. Comparison

of strictureplasty and endoscopic balloon dilatation for

stricturing Crohn’s disease—review of the literature.

Int

J Colorectal Dis.

2010 Oct;25(10):1149–57.

36. Pohl J, May A, Nachbar L, Ell C. Diagnostic and

therapeutic yield of push-and-pull enteroscopy for

symptomatic small bowel Crohn’s disease strictures.

Eur

J Gastroenterol Hepatol.

2007 Jul;19(7):529–34.

37. Fukumoto A, Tanaka S, Yamamoto H, et al. Diagno-

sis and treatment of small-bowel stricture by double

balloon endoscopy.

Gastrointest Endosc.

2007Sep;66(3

Suppl):S108–12.

38. Hirai F, Beppu T, Sou S, Seki T, et al. Endoscopic

balloon dilatation using double-balloon endoscopy is a

useful and safe treatment for small intestinal strictures

in Crohn’s disease.

Dig Endosc

. 2010 Jul;22(3):200–4.

39. Perez-Cuadrado E, Molina Perez E. Multiple strictures

in jejunal Crohn’s disease: push enteroscopy dilation.

Endoscopy.

2001 Feb;33(2):194.

40. Shen B, Lian L, Kiran RP, Queener E, et al. Efficacy and

safety of endoscopic treatment of ileal pouch strictures.

Inflamm Bowel Dis.

2011 Dec;17(12):2527–35.

41. Hellers G, Bergstrand O, Ewerth S, et al. Occurrence

and outcome after primary treatment of anal fistulae in

Crohn’s disease.

Gut.

1980 Jun; 21(6): 525-527.

42. Tang LY, Rawsthorne P, Bernstein CN. Are perineal and

luminal fistulas associated in Crohn’s disease? A popula-

tion-based study.

Clin Gastroenterol Hepatol.

2006 Sep;

4(9): 1130-4.

43. Schratter-Sehn AU, Lochs H, Vogelsang H, et al. Endo-

scopic ultrasonography versus computed tomography in

the differential diagnosis of perianorectal complications

in Crohn’s disease.

Endoscopy.

1993 Nov; 25(9): 582-6.

44. Orsoni P, Barthet M, Portier F, et al. Prospective

comparison of endosonography, magnetic resonance

imaging and surgical findings in anorectal fistula and

abscess complicating Crohn’s disease.

Br J Surg.

1999

Mar; 86(3): 360-4.

45. Claessen MM, Vleggaar FP, Tytgat KM, et al. High

lifetime risk of cancer in primary sclerosing cholangitis.

J Hepatol.

2009 Jan; 50(1):158-64.

46. Tischendorf JJ, Hecker H, Krüger M, et al. Character-

ization, outcome, and prognosis in 273 patients with

primary sclerosing cholangitis: A single center study.

Am

J Gastroenterol.

2007 Jan;102(1):107-14.

47. Chapman R, Fevery J, Kalloo A, et al. Diagnosis and

management of primary sclerosing cholangitis.

Hepatol-

ogy.

2010 Feb;51(2):660-78.

48. Hurlstone DP, Sanders DS, Atkinson R, et al. Endo-

scopic mucosal resection for flat neoplasia in chronic

ulcerative colitis: can we change the endoscopic man-

agement paradigm?

Gut.

2007 Jun; 56(6): 838-846.

49. Rutter MD, Saunders BP, Wilkinson KH, et al. Thir-

ty-year analysis of a colonoscopic surveillance program

for neoplasia in ulcerative colitis.

Gastroenterology.

2006

Apr;130(4):1030–8.

50. Eaden JA, Abrams KR, Mayberry JF. The risk of col-

orectal cancer in ulcerative colitis: a meta-analysis.

Gut.

2001 Apr; 48(4): 526-35.

51. Gillen CD, Walmsley RS, Prior P, et al. Ulcerative

colitis and Crohn’s disease: a comparison of the

colorectal cancer risk in extensive colitis.

Gut.

1994

Nov;35(11):1590–2.

52. Ekbom A, Helmick C, Zack M, et al. Increased risk

of large-bowel cancer in Crohn’s disease with colonic

involvement. Lancet. 1990; 336: 357-359.

53. Subramanian V, Ramappa V, Telakis E, et al. Com-

parison of high definition with standard white light

endoscopy for detection of dysplastic lesions during

surveillance colonoscopy in patients with colon-

ic inflammatory bowel disease.

Inflamm Bowel Dis.

2013;19(2):350–5.

54. Hurlstone DP, Sanders DS, Lobo AJ, et al. Indigo

carmine-assisted high-magnification chromoscopic

colonoscopy for the detection and characterisation of

intraepithelial neoplasia in ulcerative colitis: a prospec-

tive evaluation.

Endoscopy.

2005 Dec; 37(12): 1186-92.

55. Rutter MD, Saunders BP, Schofield G, et al. Pancolonic

indigo carmine dye spraying for the detection of dyspla-

sia in ulcerative colitis.

Gut.

2004 Feb;53(2): 256–60.

56. Van den Broek FJ, Stokkers PC, et al. Random biopsies

taken during colonoscopic surveillance of patients with

longstanding ulcerative colitis: low yield and absence

of clinical consequences.

Am J Gastroenterol.

2014

May;109(5):715-22.

57. Kiesslich R, Fritsch J, Holtmann M, et al. Methylene

blue-aided chromoendoscopy for the detection of

intraepithelial neoplasia and colon cancer in ulcerative

colitis.

Gastroenterology.

2003 Apr;124(4):880–8.